NCT01806779View on ClinicalTrials.gov

Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions
Nicotine Dependence
Interventions
DRUG

Chantix

DRUG

Zyban

DRUG

Nicotine patches

All participants will receive 21 mg/24 h dose nicotine (nic.) patches for 1 week.

Trial Locations (4)

27103

Duke Center for Smoking Cessation, Winston-Salem

27609

Duke Center for Smoking Cessation, Raleigh

27705

Duke Center for Smoking Cessation, Durham

28210

Duke Center for Smoking Cessation, Charlotte

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Philip Morris USA, Inc.

INDUSTRY

lead

Duke University

OTHER